top of page
Become a Clinical Study Site with Vaginal Biome Science
Only 4% of all healthcare research and development is targeted specifically at women’s health issues. Applying the last twenty years of gut microbiome research and the resulting billion dollar pivot to probiotic therapies to the vaginal microbiome makes sense.
And yet, the complex vaginal microbiome has yet to benefit from the substantial body of research that has been done on most other parts of the body.
Clinical Studies
Through clinical studies, Vaginal Biome Science is actively investigating the impact of a healthy vaginal microbiome on overall health and wellness, sexual satisfaction, and disease prevention and treatment outcomes. In parallel, we are developing new approaches to both diagnostics and therapeutics to support the restoration and maintenance of vaginal microbiome health.
Exploring the Vaginal Microbiome in the VENUS Study: New Horizons for Women's Vaginal Health
The vaginal microbiome is a delicate and intricate ecosystem. When in balance, it helps maintain vaginal health and protects against infections. However, disturbances in this microbial community called dysbiosis can lead to conditions such as bacterial vaginosis, candidiasis, urinary tract infections, sexually transmitted diseases, and many other vaginal and vulvar disorders. The “Vaginal Ecosystem and Network in the US” (VENUS) study promises to reveal the complex dynamics of the vaginal microbiome and its crucial role in various gynecological conditions to transform our understanding and improve treatment options for women suffering with vaginal health issues. VENUS is a cross-sectional study involving up to 3,250 cis-gender, US-based women aged 18 to 89, including both healthy individuals and those with various gynecological conditions. Our primary objective is to analyze the diversity of the vaginal microbiome taken at the time of a doctor’s diagnosis using both NGS and our comprehensive vaginal microbiota qPCR panel. By doing so, we hope to correlate specific microbial compositions, abundances, antibiotic resistance profiles, and more with clinical symptoms and outcomes to revolutionize how we diagnose and manage these conditions. If you would like to learn more about becoming a study site with Vaginal Biome Science, contact our Chief Science Officer at CSO@vaginalbiomescience.com.
bottom of page